tiprankstipranks
Trending News
More News >
enGene Holdings (ENGN)
NASDAQ:ENGN
US Market
Advertisement

enGene Holdings (ENGN) Similar Stocks

Compare
121 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
enGene Holdings
$8.89
$379.33M
29.59%
6 Buy
0 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$42.98
$377.72M
359.68%
5 Buy
0 Hold
0 Sell
Strong Buy
Capricor Therapeutics
$7.62
$341.96M
-55.98%
9 Buy
0 Hold
0 Sell
Strong Buy
Replimune Group
$4.63
$356.72M
-60.70%
2 Buy
5 Hold
2 Sell
Hold
Immuneering
$6.24
$369.84M
181.08%
5 Buy
0 Hold
0 Sell
Strong Buy
Contineum Therapeutics, Inc. Class A
$12.16
$319.40M
-26.44%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ENGN
enGene Holdings
8.89
2.03
29.59%
TVRD
Tvardi Therapeutics
42.98
33.85
370.76%
CAPR
Capricor Therapeutics
7.62
-9.52
-55.54%
REPL
Replimune Group
4.63
-6.49
-58.36%
IMRX
Immuneering
6.24
4.02
181.08%
CTNM
Contineum Therapeutics, Inc. Class A
12.16
-4.37
-26.44%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis